The economic evaluation of hematopoietic growth factors in high dose chemotherapy, Anti Cancer Drugs, vol.9, pp.917-924, 1998. ,
Peripheral blood progenitor cell transplantation: clinical, practical and economic considerations, J Hematother, vol.3, pp.331-348, 1994. ,
The costs of peripheral blood progenitor cell reinfusion mobilised by granulocyte colony-stimulating factor following high dose melphalan as compared with conventional therapy in multiple myeloma, Eur J Cancer, vol.30, pp.457-459, 1994. ,
Peripheral blood stem cells and bone marrow transplantation for solid tumors and lymphomas: hematologic recovery and costs. A randomized controlled trial, Ann Intern Med, vol.126, pp.600-607, 1997. ,
Early discharge after high-dose melphalan and peripheral blood stem cell reinfusion in patients with hematological and non-hematological disease, Leuk Lymphoma, vol.50, pp.80-84, 2009. ,
Case-control comparison of at-home to total hospital care for autologous stem-cell transplantation for hematologic malignancies, J Clin Oncol, vol.24, pp.4855-4861, 2006. ,
Outpatient-based peripheral blood stem cell transplantation for patients with multiple myeloma, Hematol J, vol.5, pp.222-226, 2004. ,
Costs of care associated with high-dose therapy and autologous transplantation for non-Hodgkin's lymphoma: results from the University of Nebraska Medical Center, Bone Marrow Transplant, vol.24, pp.679-684, 1989. ,
Lack of caregivers limits use of outpatient hematopoietic stem cell transplant program, Bone Marrow Transplant, vol.30, pp.741-748, 2002. ,
High-dose chemotherapy followed by autologous blood cell transplantation: a safe and effective outpatient approach, Bone Marrow Transplant, vol.20, pp.431-434, 1997. ,
Feasibility and cost-effectiveness of outpatient autotransplants in multiple myeloma, Bone Marrow Transplant, vol.20, pp.445-450, 1997. ,
Outpatient autologous hematopoietic stem cell transplantation for patients with relapsed follicular lymphoma, Ann Hematol, vol.85, pp.723-729, 2006. ,
Performing allogeneic and autologous hematopoietic SCT in the outpatient setting: effects on infectious complications and early transplant outcomes, Bone Marrow Transplant, vol.45, pp.1220-1226, 2010. ,
Outpatient high-dose chemotherapy with autologous stem-cell rescue for hematologic and nonhematologic malignancies, J Clin Oncol, vol.15, pp.11-17, 1997. ,
The use of intensive clinic support to permit outpatient autologous bone marrow transplantation for breast cancer, Semin Oncol, vol.21, issue.7, pp.25-31, 1994. ,
Outpatient-based bone marrow transplantation for hematologic malignancies: cost saving or cost shifting?, J Clin Oncol, vol.17, pp.2811-2818, 1999. ,
A comparison of inpatient and outpatient ASCT, Bone Marrow Transplant, vol.26, pp.389-395, 2000. ,
Outpatient or inpatient stem cell transplantation: patria est ubicunque est bene?, Leuk Lymphoma, vol.50, pp.3-5, 2009. ,
High-dose chemotherapy with autologous stem cell rescue in the outpatient setting, Oncology (Huntingt), vol.14, pp.91-92, 2000. ,
The use of intensive clinic support to permit outpatient autologous bone marrow transplantation for breast cancer, Semin Oncol, vol.21, issue.7, pp.25-31, 1994. ,
Outpatient management of autologous haematopoietic cell transplantation: the Barcelona experience, Presse Med, vol.33, pp.479-481, 2004. ,
At home management of aplastic phase following high-dose chemotherapy with stem-cell rescue for hematological and non-hematological malignancies, Ann Oncol, vol.10, pp.511-517, 1999. ,
Autologous hematopoietic stem cell transplants that utilize total body irradiation can safely be carried out entirely on an outpatient basis, Bone Marrow Transplant, vol.38, pp.757-764, 2006. ,